Skip to main content
. Author manuscript; available in PMC: 2009 Nov 1.
Published in final edited form as: Int J Cancer. 2008 Nov 1;123(9):2031–2040. doi: 10.1002/ijc.23732

Table 3.

Concentration of TPFs in medium conditioned by tumor cells (TCM), by doxorubicin-treated tumor cells (DTCM) and in fresh medium (FM) supplemented with tumor cell lysate

Media Cytokines (pg/1×106cells)
IL-6 CXCL8 CCL2 CXCL1 VEGF
TCM 59,044 13,934 178 182 2098
DTCM 108,263* 198,000* 271* 447* 2968*
FM + tumor cells lysates 122 68 12 78 4
FM + drug-treated cell lysates 150 67 10 60 4

H460 tumor cells were cultured in a 6-well plate (2×106/well/2 ml) in the presence or absence of doxorubicin (0.125 μg/ml) for 24h. Supernatants were collected, remaining cells were harvested and sonicated, and tumor lysates were centrifuged to remove cell debris. Tumor cell lysates (equivalent to 1×106tumor cells) were added to 1 ml of fresh culture medium. The concentrations of cytokines in media conditioned by untreated tumor cells (TCM), doxorubicin-treated tumor cells (DTCM) or fresh media (FM) conditioned by tumor lysates were determined using a Luminex multiplex assay.

*

Significantly (p<0.05) differ from other groups.

HHS Vulnerability Disclosure